RankingsPricing
  1. JP-listed companies
  2. TOWA PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Capital expenditures

TOWA PHARMACEUTICAL CO.,LTD.【JP:4553】

Market cap
¥186.5B
P/E ratio
10.1x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCapital expenditures (Million JPY)YoY (%)
Mar 31, 2025-28,736-24.08%
Mar 31, 2024-37,851+31.74%
Mar 31, 2023-28,731+157.91%
Mar 31, 2022-11,140+21.92%
Mar 31, 2021-9,137+100.86%
Mar 31, 2020-4,549-59.18%
Mar 31, 2019-11,143-23.02%
Mar 31, 2018-14,476-29.34%
Mar 31, 2017-20,488+51.16%
Mar 31, 2016-13,554+1.75%
Mar 31, 2015-13,321

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)